| Variation | | Type (Consequence) | Condition | Classification, Review status |
|---|
| | | Single nucleotide variant (missense variant) | Familial medullary thyroid carcinoma +5 more | |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia, type 2 +4 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia, type 2 | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia, type 2 +3 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +9 more | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | GPathogenic/Likely pathogenic |
| | | Indel (missense variant) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia, type 2 +10 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +16 more | GPathogenic/Likely pathogenic |
Click to view in NCBI Gene